Trying to treat most food allergies, drug developer Alladapt raises $119M
The company three months ago started a clinical trial of its lead oral drug.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: Allergy | Allergy & Immunology | American Health | Clinical Trials | Food Allergy | Health Management